BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang H, Lin J, Shen Y, Pan J, Wang C, Cheng L. Protective Effect of Crocin on Immune Checkpoint Inhibitors-Related Myocarditis Through Inhibiting NLRP3 Mediated Pyroptosis in Cardiomyocytes via NF-κB Pathway. JIR 2022;Volume 15:1653-66. [DOI: 10.2147/jir.s348464] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Sabaa M, Sharawy MH, El-Sherbiny M, Said E, Salem HA, Ibrahim TM. Canagliflozin interrupts mTOR-mediated inflammatory signaling and attenuates DMBA-induced mammary cell carcinoma in rats. Biomed Pharmacother 2022;155:113675. [PMID: 36115110 DOI: 10.1016/j.biopha.2022.113675] [Reference Citation Analysis]
2 Habimana O, Modupe Salami O, Peng J, Yi GH. Therapeutic Implications of Targeting Pyroptosis in Cardiac-related Etiology of Heart Failure. Biochem Pharmacol 2022;:115235. [PMID: 36044938 DOI: 10.1016/j.bcp.2022.115235] [Reference Citation Analysis]
3 Mauro AG, Mezzaroma E, Toldo S, Melendez G, Franco RL, Lesnefsky EJ, Abbate A, Hundley WG, Salloum FN. NLRP3-mediated Inflammation in CardioOncology: Sterile yet Harmful. Translational Research 2022. [DOI: 10.1016/j.trsl.2022.08.004] [Reference Citation Analysis]
4 Long Q, Li L, Yang H, Lu Y, Yang H, Zhu Y, Tang Y, Liu C, Yuan J. SGLT2 inhibitor, canagliflozin, ameliorates cardiac inflammation in experimental autoimmune myocarditis. Int Immunopharmacol 2022;110:109024. [PMID: 35841866 DOI: 10.1016/j.intimp.2022.109024] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]